Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima, 1-78-1 Sho-machi, Tokushima, Japan.
Int J Pharm. 2011 May 30;410(1-2):153-60. doi: 10.1016/j.ijpharm.2011.03.001. Epub 2011 Mar 8.
The successful delivery of therapeutic siRNA to the designated target cells and their availability at the intracellular site of action are crucial requirements for successful RNAi therapy. In the present study, we focused on the siRNA-lipoplex preparation procedure and its effect on the gene-knockdown efficiency of siRNA in vitro. Agitation (vortex-mixing) during siRNA-lipoplex (vor-LTsiR) preparation and its effect on the gene-knockdown efficiency of stably expressed cell GFP was investigated, and their efficiency was compared with that of spontaneously formed lipoplex (spo-LTsiR). A dramatic difference in size between lipoplexes was observed at the N/P ratio of 7.62 (siRNA dose of 30 nM), even though both lipoplexes were positively charged. With the siRNA dose of 30 nM, vor-LTsiR accomplished a 50% gene-knockdown, while spo-LTsiR managed a similar knockdown effect at the 120 nM level, suggesting that the preparation procedure remarkably affects the gene-knockdown efficacy of siRNA. The uptake of vor-LTsiR was mainly via clathrin-mediated endocytosis, whereas that of spo-LTsiR was via membrane fusion. In addition, by inhibiting clathrin-mediated endocytosis, the gene-knockdown efficiency was significantly lowered. The size of the lipoplex, promoted by the preparation procedure, is likely to define the entry pathway, resulting in an increased amount of siRNA internalized in cells and an enhanced gene-knockdown efficacy. The results of the present study definitively show that a proper siRNA-lipoplex preparation procedure makes a significant contribution to the efficiency of cellular uptake, and thereby, to the gene-knockdown efficiency of siRNA.
将治疗性 siRNA 递送到指定的靶细胞并使其在细胞内作用部位可用是 RNAi 治疗成功的关键要求。在本研究中,我们专注于 siRNA-脂质体复合物的制备程序及其对 siRNA 体外基因敲低效率的影响。研究了 siRNA-脂质体复合物(vor-LTsiR)制备过程中的搅拌(涡旋混合)及其对稳定表达细胞 GFP 基因敲低效率的影响,并将其与自发形成的脂质体复合物(spo-LTsiR)的效率进行了比较。在 N/P 比为 7.62(siRNA 剂量为 30 nM)时,观察到脂质体复合物之间的大小存在明显差异,尽管两者均带正电荷。当 siRNA 剂量为 30 nM 时,vor-LTsiR 可实现 50%的基因敲低,而 spo-LTsiR 在 120 nM 水平上可实现类似的敲低效果,表明制备程序可显著影响 siRNA 的基因敲低效果。vor-LTsiR 的摄取主要通过网格蛋白介导的内吞作用,而 spo-LTsiR 的摄取则通过膜融合。此外,通过抑制网格蛋白介导的内吞作用,基因敲低效率显著降低。由制备程序促进的脂质体复合物的大小可能决定进入途径,从而使更多的 siRNA 内化到细胞中并增强基因敲低效果。本研究的结果明确表明,适当的 siRNA-脂质体复合物制备程序可显著提高细胞摄取效率,从而提高 siRNA 的基因敲低效率。